RE:RE:Nice Read TLT is dealing with layer upon layer of bureaucracy and regulation so yeah it is slooooooow.
But I think/hope we get noticed and rolling long before 2025...
But having said that, I wonder how many indications will be pursued at that point? I would think if GBM - for example get announced this year and due to the nature of that death sentence gets trialed with urgency with result say by 2023...maybe. And IF the phase 1b GBM trial cracks the IV nut, many more trials would be possible.
But this also gets back to the old question: Does NSCLC really need a PH 1b it topically applied? Hopefully we find out soon and Laser's astute speculation on Medtronics starts to play out.
Back on point. I hope TLT has several irons in the fire and some licensed partners by 2025 and a shareprice well into the double digits.
Or we see a bidding war before then...as Dr Sherri's magic compounds become better understood.
FWIIW.